[{"address1": "1150 Veterans Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "925 407 1049", "website": "https://www.nkartatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.", "fullTimeEmployees": 157, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul J. Hastings", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 935183, "exercisedValue": 0, "unexercisedValue": 1858112}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.705, "open": 1.63, "dayLow": 1.59, "dayHigh": 1.685, "regularMarketPreviousClose": 1.705, "regularMarketOpen": 1.63, "regularMarketDayLow": 1.59, "regularMarketDayHigh": 1.685, "payoutRatio": 0.0, "beta": 0.839, "forwardPE": -0.9261364, "volume": 1154435, "regularMarketVolume": 1154435, "averageVolume": 1491541, "averageVolume10days": 4009550, "averageDailyVolume10Day": 4009550, "bid": 1.58, "ask": 1.66, "bidSize": 1, "askSize": 4, "marketCap": 115660888, "fiftyTwoWeekLow": 1.31, "fiftyTwoWeekHigh": 9.52, "fiftyDayAverage": 1.9262, "twoHundredDayAverage": 3.684225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -71420184, "profitMargins": 0.0, "floatShares": 48884788, "sharesOutstanding": 70957600, "sharesShort": 9402057, "sharesShortPriorMonth": 9623089, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1331, "heldPercentInsiders": 0.05234, "heldPercentInstitutions": 0.99446, "shortRatio": 9.23, "shortPercentOfFloat": 0.17639999, "impliedSharesOutstanding": 70957600, "bookValue": 5.775, "priceToBook": 0.2822511, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -108790000, "trailingEps": -1.6, "forwardEps": -1.76, "enterpriseToEbitda": 0.6, "52WeekChange": -0.8160271, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 1.63, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.5, "targetMedianPrice": 15.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 267354000, "totalCashPerShare": 3.768, "ebitda": -119042000, "totalDebt": 80273000, "quickRatio": 14.133, "currentRatio": 14.449, "debtToEquity": 19.676, "returnOnAssets": -0.18208, "returnOnEquity": -0.31938, "freeCashflow": -64143248, "operatingCashflow": -99696000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NKTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "corporateActions": [], "postMarketTime": 1743807733, "regularMarketTime": 1743796801, "shortName": "Nkarta, Inc.", "longName": "Nkarta, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -4.3988295, "regularMarketPrice": 1.63, "cryptoTradeable": false, "postMarketChangePercent": 2.34356, "postMarketPrice": 1.6682, "postMarketChange": 0.0382, "regularMarketChange": -0.07500005, "regularMarketDayRange": "1.59 - 1.685", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1491541, "fiftyTwoWeekLowChange": 0.32000005, "fiftyTwoWeekLowChangePercent": 0.24427485, "fiftyTwoWeekRange": "1.31 - 9.52", "fiftyTwoWeekHighChange": -7.8900003, "fiftyTwoWeekHighChangePercent": -0.8287815, "fiftyTwoWeekChangePercent": -81.60271, "earningsTimestamp": 1743019260, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.6, "epsForward": -1.76, "epsCurrentYear": -1.45, "priceEpsCurrentYear": -1.1241379, "fiftyDayAverageChange": -0.29620004, "fiftyDayAverageChangePercent": -0.15377429, "twoHundredDayAverageChange": -2.054225, "twoHundredDayAverageChangePercent": -0.55757314, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.3 - Strong Buy", "exchange": "NMS", "messageBoardId": "finmb_544531597", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Nkarta", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]